Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novartis launches Gleevec in U.S. for treatment of CML

May 18, 2001

Biomed-101 increases drug tolerance in phase I renal cancer trial

May 17, 2001

Antitumor efficacy of SarCNU correlated with EMT and MGMT expression

May 17, 2001

Phytera and Gemin X establish alliance for discovery of novel anticancer agents

May 17, 2001

Eligix to begin phase III evaluation of BCell-HDM system

May 17, 2001

Clinical trial results with Thalomid in early-stage and refractory multiple myeloma reported

May 17, 2001

AstraZeneca identifies quinazoline derivatives as inhibitors of aurora2 kinase

May 16, 2001

AGI Dermatics reports promising results with skin cancer prevention drug

May 16, 2001

Inhibitors of protein prenyltransferases identified by Dutch researchers

May 15, 2001

Introgen's INGN-241 demonstrates potent antitumor properties in preclinical studies

May 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...